Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlortetracycline hydrochloride [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Chlortetracycline HCl [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Chlortetracycline hydrochloride 10 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Chlortetracycline hydrochloride [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Chlortetracycline hydrochloride 3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
|
Chlortetracycline hydrochloride 10 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
1 |
Chlortetracycline hydrochloride 10 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortetracycline hydrochloride |
Inferred relationship |
Some |
1 |